Evidence map›Paper›PMID 27128791›Full record

ArticleLab on a chip2016

Implantable tissue isolation chambers for analyzing tumor dynamics in vivo.

Gabriel Gruionu, Despina Bazou, Nir Maimon, Mara Onita-Lenco, Lucian G Gruionu, Peigen Huang, Lance L Munn

Abstract read
In one paragraph

Article in Lab on a chip, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Self-assembly of vascularized tissue to support tumor explants in vitro.Integrative biology : quantitative biosciences from nano to macro · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Gabriel GruionuEdwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. munn@steele.mgh.harvard.edu.
Despina Bazou
Nir Maimon
Mara Onita-Lenco
Lucian G Gruionu
Peigen Huang
Lance L Munn
Harvard University · USMassachusetts General Hospital · USSteinhauser (Czechia) · CZUniversitas Islam Negeri Sumatera Utara · ID

Funding

Systems biology of lymphatic transportR01HL128168 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L., PADERA, TIMOTHY P · 2015 to 2019
$2.9M
Encouraging anastomosis of engrafted vascular networksR01HL106584 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L. · 2012 to 2015
$1.3M
Flow-based remodeling and function of tumor vasculatureR01CA149285 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L. · 2010 to 2013
$1.3M
NCI NIH HHS R01 CA149285NHLBI NIH HHS R01 HL106584NHLBI NIH HHS R01 HL128168
6 · The paper itself

Abstract

Recruitment of new blood vessels from the surrounding tissue is central to tumor progression and involves a fundamental transition of the normal, organized vasculature into a dense disarray of vessels that infiltrates the tumor. At present, studying the co-development of the tumor and recruited normal tissue is experimentally challenging because many of the important events occur rapidly and over short length scales in a dense three-dimensional space. To overcome these experimental limitations, we partially confined tumors within biocompatible and optically clear tissue isolation chambers (TICs) and implanted them in mice to create a system that is more amenable to microscopic analysis. Our goal was to integrate the tumor into a recruited host tissue - complete with vasculature - and demonstrate that the system recapitulates relevant features of the tumor microenvironment. We show that the TICs allow clear visualization of the cellular events associated with tumor growth and progression at the host-tumor interface including cell infiltration, matrix remodeling and angiogenesis. The tissue within the chamber is viable for more than a month, and the process is robust in both the skin and brain. Treatment with losartan, an angiotensin II receptor antagonist, decreased the collagen density and fiber length in the TIC, consistent with the known activity of this drug. We further show that collagen fibers display characteristic tumor signatures and play a central role in angiogenesis, guiding the migration of tethered endothelial sprouts. The methodology combines accessible methods of microfabrication with animal models and will enable more informative studies of the cellular mechanisms of tumor progression.

Indexed as

Implants, ExperimentalAnimalsBiocompatible MaterialsBlood VesselsBrainCollagenDimethylpolysiloxanesEquipment DesignFibroblastsLosartanMacrophagesMice, TransgenicNeovascularization, PathologicOrgan Culture TechniquesStromal CellsTumor MicroenvironmentBiocompatible MaterialsCollagenDimethylpolysiloxanesLosartan

Identifiers

PMID27128791
PMCPMC5155583
OpenAlexW2339539273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.